Career history of Harvey N. Masonson
Former positions of Harvey N. Masonson
Companies | Position | Start | End |
---|---|---|---|
GENSIGHT BIOLOGICS S.A. | Chief Tech/Sci/R&D Officer | 2017-12-31 | 2018-12-31 |
BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - | - |
(OSI) Eyetech
(OSI) Eyetech Medical SpecialtiesHealth Technology OSI Eyetech provides medical services. It is specializee in the development and commercialization of therapeutics to treat diseases of the eye. The company is headquartered in New York City, NY. | Corporate Officer/Principal | - | - |
Sanofi-Synthelabo, Inc. | Chief Tech/Sci/R&D Officer | - | - |
IVERIC BIO, INC. | Chief Tech/Sci/R&D Officer | - | - |
Training of Harvey N. Masonson
Icahn School of Medicine at Mount Sinai | Doctorate Degree |
Statistics
International
United States | 6 |
France | 2 |
Operational
Chief Tech/Sci/R&D Officer | 3 |
Corporate Officer/Principal | 2 |
Doctorate Degree | 1 |
Sectoral
Health Technology | 6 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
GENSIGHT BIOLOGICS S.A. | Health Technology |
Private companies | 3 |
---|---|
(OSI) Eyetech
(OSI) Eyetech Medical SpecialtiesHealth Technology OSI Eyetech provides medical services. It is specializee in the development and commercialization of therapeutics to treat diseases of the eye. The company is headquartered in New York City, NY. | Health Technology |
IVERIC bio, Inc.
IVERIC bio, Inc. Pharmaceuticals: GenericHealth Technology IVERIC bio, Inc. operates as a biopharmaceutical company. The firm engages in discovering, developing and commercializing novel therapeutics to treat ophthalmic diseases, with a focus on age-related and orphan retinal diseases. Its product candidates include Zimura and Gene Therapy. The company was founded by David R. Guyer and Samir Chandrakant Patel on January 5, 2007 and is headquartered in Parsippany, NJ. | Health Technology |
Sanofi-Synthelabo, Inc. | Health Technology |
- Stock Market
- Insiders
- Harvey N. Masonson
- Experience